NCT02929134View on ClinicalTrials.gov

A 24 Month Study to Compare Efficacy of Doxycycline vs Placebo for Improving Filarial Lymphedema in Sri Lanka

PHASE3CompletedINTERVENTIONAL
Enrollment

219

Participants

Timeline

Start Date

February 16, 2018

Primary Completion Date

June 15, 2020

Study Completion Date

June 15, 2020

Conditions
LymphedemaLymphatic FilariasisFilariasis
Interventions
DRUG

Doxycycline

Once daily tablet for 6 weeks: Doxycycline hyclate 200 mg per day x 6 weeks for patients \>50 kg or 100 mg per day for patients \<50 kg)

DRUG

Placebo

Once daily tablet for 6 weeks: matching tablets containing no active ingredients

Trial Locations (1)

091

University of Ruhuna, Galle

All Listed Sponsors
collaborator

United States Agency for International Development (USAID)

FED

lead

The Task Force for Global Health

OTHER

NCT02929134 - A 24 Month Study to Compare Efficacy of Doxycycline vs Placebo for Improving Filarial Lymphedema in Sri Lanka | Biotech Hunter | Biotech Hunter